Clinical Trial Update: Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update evaluating adipose-derived regenerative cells for glaucomatous neurodegeneration, including retinal degeneration and primary o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma
• Retinal Degeneration

Drugs mentioned

• Adipose-Derived Regenerative Cells (ADRCs) (adipose-derived regenerative cells)

Snippet

Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Conditions: Retinal Degeneration, Primary Open-Angle Glaucoma | Phase 1, Phase 2 | Status: UNKNOWN